Sterling Consolidated Corp. STCC
Last Post: 11/29/2018 11:18:53 AM
Board Marks: 4
Posts Today: 0
Board Views Today: 21
03/20/2017 3:04:23 PM
03/20/2017 3:03:27 PM
03/20/2017 3:00:27 PM
03/13/2017 2:38:22 PM
03/13/2017 2:36:31 PM
03/13/2017 2:34:32 PM
03/13/2017 2:32:45 PM
03/13/2017 2:30:30 PM
03/09/2017 1:51:28 PM
03/09/2017 1:49:24 PM
03/09/2017 1:47:35 PM
03/09/2017 1:46:49 PM
03/09/2017 1:45:28 PM
03/08/2017 2:51:41 PM
03/08/2017 2:47:55 PM
03/08/2017 2:45:51 PM
03/08/2017 2:44:25 PM
03/08/2017 2:42:57 PM
03/07/2017 1:59:07 PM
03/07/2017 1:57:01 PM
03/07/2017 1:55:27 PM
03/07/2017 1:51:07 PM
03/07/2017 1:49:51 PM
03/06/2017 3:10:59 PM
03/06/2017 3:07:00 PM
03/06/2017 2:59:21 PM
03/06/2017 2:55:43 PM
03/02/2017 1:27:26 PM
03/02/2017 1:24:10 PM
03/02/2017 1:21:38 PM
03/02/2017 1:19:09 PM
03/01/2017 2:28:34 PM
03/01/2017 2:27:04 PM
03/01/2017 2:24:29 PM
03/01/2017 2:20:04 PM
03/01/2017 2:16:17 PM
02/28/2017 1:11:25 PM
02/28/2017 1:08:36 PM
02/28/2017 1:06:33 PM
02/28/2017 1:04:09 PM
02/28/2017 1:00:47 PM
02/27/2017 12:31:13 PM
02/27/2017 12:28:21 PM
02/27/2017 12:24:24 PM
02/27/2017 12:23:07 PM
02/27/2017 12:21:39 PM
02/23/2017 2:51:06 PM
02/23/2017 2:49:56 PM
02/23/2017 2:48:18 PM
02/13/2017 12:49:24 PM
Recent Articles
- Nextensa and Promobe Secure Long-Term Lease for New Offices
- China's Rare Earth Controls: An Uncertain Gamble Ahead
- Transform Your Finances: The Military Money Manual Unveiled
- FORVIA Reports Steady Q3 2025 Sales of €6.1 Billion
- High-Dose Influenza Vaccine Promises Greater Protection for Seniors
- Corbion Share Buyback Program Update: Significant Progress Made
- Roche's Gazyva/Gazyvaro Receives FDA Approval for Lupus Nephritis
- Vow ASA Reports Mixed Q3 Performance Amid Strong Market Demand
- TGS Secures Major OBN Acquisition Contract for Gulf of America
- Advancements in Bladder Cancer Treatment: Roche's Tecentriq Impact
- Sanofi's High-Dose Flu Vaccine Outperforms Standard Dosage
- ARTIS Zoo's New Certification: A Win for Urban Wildlife
- Zeekr Group to Release Q3 Financial Results; What's Next?
- Comfone Unveils Global 5G Standalone Roaming Services
- ARTIS Zoo Becomes Europe's First Certified Night Sky Place
- Tim Cook Applauds China's Remarkable Contribution to Apple
- Highlights from the 2025 World Internet Conference Preview
- Exploring the Essence of China-South Korea Relations Through Art
- Marko Law Firm Expands Footprint to Better Serve Michigan Residents
- Quantitative Brokers Unveils Advanced Trading Solutions in Brazil
- HTX's Airdrop Initiative: Supporting Traders Amid Market Chaos
- Insights on the AI Boom: Evaluating Valuations and Investment Opportunities
- Kyndryl's Latest AI Readiness Insights Sparks Transformation
- Tesla's Upcoming Earnings: Focus on Robotaxis and AI Integration
- Trump's Warning: Supreme Court Ruling May Harm U.S. Economy
- BC.GAME Esports Welcomes CS Major Champion electronic to Squad
- Elon Musk Defends Tesla's CEO Compensation Amid Criticism
- Chery Group Strengthens Commitment to Global Education Initiatives
- Revolutionizing Workplace Comfort with Elevated Seating Innovation
- Established Tech Giants Poised to Lead in AI Development
- ENGWE's Innovative Journey: Connecting E-Bike Riders Worldwide
- Investigation Ongoing After Daring Jewelry Heist at Louvre
- Unveiling Sustainable Solutions: Insights from Global Leaders
- SKYWORTH Launches Revolutionary Matte Screen Ultra TV Series
- Exciting Advances in Lung Cancer Treatment with Sacituzumab Tirumotecan
- MoonLake Immunotherapeutics: A Call to Action for Investors
- Investors Urged to Act Quickly in PubMatic Class Action Suit
- Tragic Cargo Plane Incident at Hong Kong Airport Sparks Concerns
- Christine Lagarde's Insight: Upcoming Tariff Effects on U.S. Consumers
- Insights on the Upcoming Financial Street Forum in Beijing
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
